<p>Clinical efficacy and safety of rituximab in lupus nephritis</p>
Lists
Only you see this
Abstract
RTX is a promising therapy for the treatment of LN due to significant clinical efficacy and a favorable safety profile. In future studies, larger study populations and longer-term time points may identify additional important patient-centered outcomes.
BibTeX
@inproceedings{zhong2019lt,
author = {Zhiqing Zhong and Hongyan Li and Hongzhen Zhong and Tian‐Biao Zhou},
title = {{\<p\>Clinical efficacy and safety of rituximab in lupus nephritis\</p\>}},
booktitle = {Drug},
year = {2019},
doi = {10.2147/dddt.s195113},
}Loading related content...